Prognostic Assessment of Contrast Echocardiography (PACE Study)

Stopped early

Conditions studied: Coronary Artery Disease

In brief

This study will demonstrate whether patients with prognostically-significant myocardial abnormalities detected with AI-700 contrast ECHO have a rate of cardiac death or MI that is higher than that of patients with normal AI-700 contrast ECHO.

Key facts

Study ID

NCT00670332

Run by

Acusphere

People needed

773

Starts

2007-07-01

Last updated by the study team

2008-05-01

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Acusphere — Watertown, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.